Study recruitment: Researchers looking at treatments for Covid-19 and risk of complications for additional health conditions including diabetes
People with diabetes invited to participate in study if they have been diagnosed with Covid-19.
Researchers at the University of Oxford are looking for people with diabetes who have also been diagnosed with Covid-19 to take part in a clinical study looking at new treatments for the virus. The aim of the PANORAMIC clinical study is to find new treatments that help people with Covid-19 at home and in the community get better quicker and without needing to be treated in hospital.
Researchers said: “Most people with Covid-19 are treated in the community and so we need to find treatments that are suitable and effective for use early on in the illness.
“Covid-19 can cause great suffering, and it stops people from performing their daily activities, affecting their work, education, and caring responsibilities. The risk of complications from Covid-19 is increased in people with underlying health conditions, older people, unvaccinated people, and those in whom the vaccine is less effective. Especially in these people, Covid-19 can sometimes lead to significant medical problems, hospitalisation, and death.
“PANORAMIC aims to find out if new antiviral medicines help to keep people with Covid-19 from needing to be admitted to hospital and helps people to get better. All of the treatments in the PANORAMIC trial have been approved by the UK Medicines and Health Care Products Regulatory Agency (MHRA) for use in the study (which regulates the use of all medicines in the UK), and the study is approved by the Health Research Authority.”
The study is open to anybody that has experienced Covid-19 symptoms in the last five days and had a positive PCR or lateral flow test for Covid-19, and is aged 50 and over, or 18 and over, with a pre-existing health condition – including diabetes.
Taking part in the study will involve answering a few questions online each day for 28 days through the PANORAMIC website, or receive a phone call from the trial team on days 7, 14 and 28 to speak about your symptoms.
The trial team will also contact you at 3 and 6 months after you started the trial, where we will ask you about ant long-term Covid-19 symptoms.
You may withdraw from the trial at any stage by simply contacting the trial team.